Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-10FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' supplemental application for bupropion hydrochloride, updating the product labeling.
-
FDA approval · 2019-11-22FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
The FDA approved a supplemental application for mirtazapine from Aurolife Pharma LLC, enabling the marketed generic to proceed under an appr…
-
FDA approval · 2019-11-22FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approves a supplemental application for Quetiapine by Accord Healthcare Inc., granting regulatory approval for a generic version of the …
-
FDA approval · 2019-11-22FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application to market a generic mirtazapine product.
-
FDA approval · 2019-11-20FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for mirtazapine, allowing a generic version to come to market under the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-05FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) submitted by Bausch Health US LLC under NDA021515.
-
FDA approval · 2019-10-31FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved Venlafaxine hydrochloride (extended-release) from Chartwell RX, LLC under an Original Application (ANDA).
-
FDA approval · 2019-10-30FDA Approved: DESVENLAFAXINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for desvenlafaxine (generic) sponsored by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2019-10-29FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for desvenlafaxine.
-
FDA approval · 2019-10-29FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride product from Vensun Pharmaceuticals, thereby approving a generic vers…
-
FDA approval · 2019-09-30FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
The FDA approved a Supplemental Application for Desipramine hydrochloride from Ingenus Pharmaceuticals, LLC, confirming continued market ava…
-
FDA approval · 2019-09-30FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's generic vilazodone hydrochloride tablets as an original ANDA for the treatment of major depressive disorder.
-
FDA approval · 2019-09-11FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA supplemental approval granted for Apotex Corp's paroxetine hydrochloride product, approving a generic formulation under NDA 020936.
-
FDA approval · 2019-09-05FDA Approved: REMERON — Supplemental Application (Organon LLC)
FDA approved a supplemental application for REMERON (mirtazapine) from Organon LLC.
-
FDA approval · 2019-09-05FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Oryza pharmaceuticals Inc.)
FDA approved a generic version of bupropion hydrochloride extended-release (XL) from Oryza Pharmaceuticals Inc. under an original applicatio…
-
FDA approval · 2019-08-29FDA Approved: VENLAFAXINE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved a generic venlafaxine product from Modavar Pharmaceuticals LLC via an Original Abbreviated New Drug Application (ANDA). The gen…
-
FDA approval · 2019-08-26FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2019-08-16FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved the original application for duloxetine hydrochloride from Yaopharma Co., Ltd., granting approval for the generic product to be…
-
FDA approval · 2019-06-25FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)
FDA approved Janssen's supplemental application for SPRAVATO (esketamine hydrochloride), resulting in labeling changes for the product.
-
FDA approval · 2019-05-23FDA Approved: FLUOXETINE — Original Application (Cadila Pharmaceuticals Limited)
Cadila Pharmaceuticals Limited received FDA approval for an original application of fluoxetine (generic).
-
FDA approval · 2019-05-22FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for a generic duloxetine from Zydus Lifesciences Limited, authorizing marketing of the product.
-
FDA approval · 2019-05-09FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)
The FDA approved a supplemental application for SPRAVATO (esketamine hydrochloride) submitted by Janssen Pharmaceuticals.
-
FDA approval · 2019-05-07FDA Approved: DESVENLAFAXINE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved Marlex Pharmaceuticals’ generic desvenlafaxine via an original ANDA submission. This establishes a generic option for the antid…
-
FDA approval · 2019-04-17FDA Approved: DULOXETINE — Original Application (Qingdao BAHEAL Pharmaceutical Co., Ltd.)
FDA approved a generic version of duloxetine from Qingdao BAHEAL Pharmaceutical Co., Ltd. under an Original Application (ANDA 210599). The a…
-
FDA approval · 2019-04-16FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for desipramine hydrochloride, approving a generic version of desipram…